Azithromycin/loteprednol-etabonate
Alternative Names: Azithromycin/loteprednol; Loteprednol-etabonate/azithromycin; Loteprednol/azithromycinLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Adapt Produtos Oftalmologicos
- Class Androstadienes; Anti-inflammatories; Antiallergics; Antibacterials; Eye disorder therapies; Macrolides; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists; Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bacterial infections; Infectious conjunctivitis; Keratitis; Ocular inflammation
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Bacterial-infections in Brazil (Ophthalmic, Drops)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Infectious conjunctivitis in Brazil (Ophthalmic, Drops)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Keratitis in Brazil (Ophthalmic, Drops)